Le Lézard
Classified in: Health
Subjects: LAW, POL

Beacon Health Options Urges House to Support 'OPPS Act' that Modernizes Federal Privacy Laws to Combat Opioid Epidemic


BOSTON, Aug. 17, 2017 /PRNewswire/ -- Beacon Health Options (Beacon), a national leader in behavioral health management, announced today its support for the bipartisan Overdose Prevention and Patient Safety Act, "OPPS Act" of 2017 (H.R. 3545).

Beacon Health Options logo (PRNewsFoto/Beacon Health Options)

The legislation was introduced by Congressmen Tim Murphy (R-PA) and Earl Blumenauer (D-OR). The "OPPS Act" simplifies and aligns the Code of Federal Regulations Part 2 (42 CFR Part 2) with existing confidentiality protections under the Health Insurance Portability and Accountability Act (HIPAA) for the purposes of health care treatment, payment, and operations. It also strengthens protections against the use of substance use disorder (SUD) records in criminal proceedings. Currently, under 42 CFR Part 2, information about an individual's substance use disorder is not permitted to be shared with the entire medical team treating that person unless the patient has given written consent for each of those providers.

"Beacon applauds Congressmen Murphy and Blumenauer for introducing the Overdose Prevention and Patient Safety Act and urges Congressional leaders to approve this legislation as soon as possible," said Dr. Hal Levine, Beacon Health Options Chief Medical Officer. "The current segregation of SUD treatment records can be harmful and possibly deadly. If a doctor cannot review a patient's treatment history before prescribing opioids or other drugs, it can lead to a relapse for a person in recovery, and worst case scenario, an overdose or death."

Although the data is preliminary, according to a June 5, 2017 article in The New York Times, the best estimate regarding deaths due to drug overdose in 2016 is that, nationwide, it rose 19 percent over the previous year. All evidence suggests the problem is worsening in 2017. In Massachusetts, where Beacon is headquartered, the state's Department of Public Health first-quarter report on opioid-related deaths, such deaths have increased by almost 21 percent, from 1,651 in 2015, to 1,993 in 2016. In the first quarter of 2017, there have been 172 confirmed opioid overdose deaths, plus an additional 242 to 307 that have not been confirmed.

Dr. Levine added, "We are in the midst of the one of the worst SUD crises our nation has ever known. We need to use every tool available to effectively treat heroin and opioid misuse so it can no longer devastate families and destroy communities. Passing H.R. 3545 is an important step toward achieving that goal."

About Beacon Health Options
Beacon Health Options is a managed behavioral health care company that serves 50 million individuals across all 50 states and the United Kingdom. On behalf of employers, health plans and government agencies, we manage behavioral health insurance and EAP benefits to ensure that individuals have access to robust mental health and addiction services. To promote quality care, Beacon works with its provider partners to design innovative programs and solutions that directly address the challenges our behavioral health care system faces today. Beacon is a national leader in the fields of mental and emotional well-being, addiction, recovery and resilience, employee assistance, and wellness. Partnering with a network of providers nationwide, we help individuals live their lives to the fullest potential. For more information, visit www.beaconhealthoptions.com and connect with us on www.facebook.com/beaconhealthoptions, www.twitter.com/beaconhealthopt and www.linkedin.com/company/beacon-health-options.

SOURCE Beacon Health Options


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: